Xoma | XOMA - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 35.32M 2.51M 2025-12
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Ardelyx USD 244.35M 1.38M 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Celldex Therapeutics USD 66.55M 102K 2025-12
Curis USD 12.93M 12.87M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Emergent BioSolutions USD 100K 0 2023-06
Incyte USD 199.95M 1.49M 2026-03
MacroGenics USD 63.32M 60K 2025-12
Novartis USD 1.91B 60K 2026-03
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.7B 13M 2026-03
Prothena USD 53.83M 3K 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Xoma USD 87K 1000 2024-06